https://www.marketscreener.com/quote/stock/BOLT-BIOTHERAPEUTICS-INC-118683093/news/Bolt-Biotherapeutics-Enrolls-First-Patient-in-Phase-2-Clinical-Study-Evaluating-Bdc-1001-in-Patients-45503492/?utm_source=telegram&utm_medium=social&utm_campaign=share